CFDE Data Portal | Search LINC01582

	Label	Description
	LINC01582 Gene (Entity type)	ENSG00000259611 - long intergenic non-protein coding RNA 1582
	GSE173116 GSE173118 ML-7 8 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE213845 EZH2 inhibition 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE152699 GSE152723 vemurafenib 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE96649 belinostat A-549 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE112714 Ctnnb1 knockout 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE183535 MYC inhibition HeLa 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE112714 Ctnnb1 knockout 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Ovary 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Ovary 20-29 vs 60-69 Down Gene Set (Entity type)	A Gene Set from GTEx

LINC01582

ENSG00000259611 - long intergenic non-protein coding RNA 1582

GSE173116 GSE173118 ML-7 8 v 5 human dn

A Gene Set from LINCS

GSE213845 EZH2 inhibition 2 v 0 human up

A Gene Set from LINCS

GSE152699 GSE152723 vemurafenib 3 v 2 human up

A Gene Set from LINCS

GSE96649 belinostat A-549 1 v 0 human up

A Gene Set from LINCS

GSE112714 Ctnnb1 knockout 2 v 0 human dn

A Gene Set from LINCS

GSE183535 MYC inhibition HeLa 3 v 2 human up

A Gene Set from LINCS

GSE112714 Ctnnb1 knockout 2 v 3 human dn

A Gene Set from LINCS

GTEx Ovary 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Ovary 20-29 vs 60-69 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.